OpenEye Scientific is open for business and fully operational. We continue to provide close support to our clients in their efforts to find therapies for many diseases including COVID-19. OpenEye offices worldwide are closed until further notice and all work is now remote.
Academic licenses to OpenEye software continue to be available at no charge for research results that remain in the public domain, including for use in COVID-19 projects. Response time at present is 24-48 hours to receive an academic license. Please apply at the following link: https://www.eyesopen.com/academic-licensing
We have recently published our contributions to the fight against COVID-19. By utilizing Orion, OpenEye’s molecular design platform, we have identified thousands of potential therapeutics. Please read the blog post here.
OpenEye has increased its financial commitment to and is actively supporting local businesses, restaurants and charitable organizations at this difficult time. In addition to direct donations and other programs, each employee has been given $1000 to support local restaurants through the pandemic closures.